TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16607096

Group type: EXPERIMENTAL
Intervention: Early initiation of hormone therapy (HT)
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Early initiation of hormone therapy (HT) in women aged 70-79 years
Number of subjects: 428

Group type: COMPARATOR
Intervention: Late initiation of hormone therapy (HT)
Number of subjects: 428

Group type: COMPARATOR
Intervention: Late initiation of hormone therapy (HT) in women aged 60-69 years
Number of subjects: 428

Group type: COMPARATOR
Intervention: Late initiation of hormone therapy (HT) in women aged 80 years and older
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Late initiation of hormone therapy (HT) in women aged 70-79 years
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: HT users of less than 11 years
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: HT users of more than 11 years
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Estrogen‐only users
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Combined estrogen plus progestin users
Number of subjects: 428
Study: 14580130

Group type: EXPERIMENTAL
Intervention: Blocked practice
Number of subjects: 36

Group type: COMPARATOR
Intervention: Random practice
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Blocked practice and Random practice
Number of subjects: 36
Study: 10801247

Group type: EXPERIMENTAL
Intervention: Tangeretin (1 to 100 micromol/L)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tangeretin (50 micromol/L)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tangerine juice (200 mL)
Number of subjects: 8
Study: 8664811

Group type: EXPERIMENTAL
Intervention: Treatment 1 (250 mg of standard vitamin C, 200 mg of vitamin E and 6 mg of beta‐carotene three times a day)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Treatment 2 (150 mg of standard vitamin C, 500 mg of slow release vitamin C, 75 mg of vitamin E and 15 mg of beta‐carotene once a day)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 43

Group type: COMPARATOR
Intervention: H. pylori isolates
Number of subjects: 43
Study: 1477566

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 70
Study: 6703731

Group type: EXPERIMENTAL
Intervention: Modified Goeckerman therapy (hospitalized throughout average 20.8 days)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Modified Goeckerman therapy (hospitalized for 14 days, then transferred to ambulatory care for remainder of average 20.8 days)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 162
Study: 31877766

Group type: COMPARATOR
Intervention: Gal3C-S-OPN/full-length-OPN levels in stone forming urolithiasis patients
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Gal3C-S-OPN/full-length-OPN levels after ureteroscopic lithotripsy (URS)
Number of subjects: 110
Study: 29429764

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 424
Study: 27413441

Group type: EXPERIMENTAL
Intervention: Values affirmation intervention
Number of subjects: 45

Group type: COMPARATOR
Intervention: No-affirmation condition (Control)
Number of subjects: 45
Study: 25121620

Group type: EXPERIMENTAL
Intervention: MORE Energy mobile application with tailored advice and a website with background information
Number of subjects: 502

Group type: COMPARATOR
Intervention: Control group with standard information about fatigue
Number of subjects: 502
Study: 21246373

Group type: EXPERIMENTAL
Intervention: methotrexate+placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: methotrexate+cyclosporine A
Number of subjects: 40

Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 40
Study: 20672352

Group type: EXPERIMENTAL
Intervention: TACE followed by RFA on the same day
Number of subjects: 37

Group type: COMPARATOR
Intervention: RFA alone
Number of subjects: 37
Study: 17407493

Group type: EXPERIMENTAL
Intervention: 0.6 g/kg ethanol
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 9
Study: 15887427

Group type: EXPERIMENTAL
Intervention: 10 microg HPV 16 L1 VLP vaccine
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: 20 microg HPV 16 L1 VLP vaccine
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: 40 microg HPV 16 L1 VLP vaccine
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: 80 microg HPV 16 L1 VLP vaccine
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 11350534

Group type: EXPERIMENTAL
Intervention: Generic allopurinol (Normon)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Zyloric tablets
Number of subjects: 24
Study: 9129372

Group type: EXPERIMENTAL
Intervention: Short-term home-based intervention with written material and video feedback; 4 intervention sessions.
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Adult Attachment Interview administered after intervention.
Number of subjects: 1
Study: 7893586

Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg twice daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg twice daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2853497

Group type: EXPERIMENTAL
Intervention: Intensified non‐medicamentous basic therapy (fat‐modified diet and endurance training)
Number of subjects: 1139

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 1139

Group type: EXPERIMENTAL
Intervention: Clofibric acid (1.6 g)
Number of subjects: 1139
Study: 31214935

Group type: EXPERIMENTAL
Intervention: Generalist approach (PCP delivered brief intervention for substance misuse)
Number of subjects: 9639

Group type: EXPERIMENTAL
Intervention: Specialist approach (BHCs delivered brief interventions)
Number of subjects: 9639

Group type: EXPERIMENTAL
Intervention: Both approaches (Generalist and Specialist)
Number of subjects: 9639
Study: 29276166

Group type: EXPERIMENTAL
Intervention: Accelerated oxytocin titration (AOT) - initial dose 4 mU/min with increments of 4 mU/min
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard gradual oxytocin titration (GOT) - initial dose 2 mU/min with increments of 2 mU/min
Number of subjects: 79
Study: 27727383

Group type: COMPARATOR
Intervention: Surgery (n=309)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Casting (n=311)
Number of subjects: 620

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Casting
Number of subjects: 620
Study: 25636934

Group type: EXPERIMENTAL
Intervention: Maraviroc therapy
Number of subjects: 13
Study: 23496916

Group type: EXPERIMENTAL
Intervention: Intervention condition (weight loss and hypertension management trial)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Intervention condition
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Retention strategies (financial incentives, contact between assessment visits, building relationships with health center staff)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Recruitment strategies (passive approval by PCPs, part-time staff, outsourcing calls)
Number of subjects: 365
Study: 20801085

Group type: EXPERIMENTAL
Intervention: Ciclosporin A (3.5-4.0 mg/kg per day)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Ciclosporin A with intermittent prednisone (0.75 mg/kg, alternating 10 days on with 10 days off)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo with intermittent prednisone
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Ciclosporin A
Number of subjects: 153
Study: 19140649

Group type: EXPERIMENTAL
Intervention: Engaged lifestyle program (team-based competition in ill-defined problem solving)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 16600770

Group type: EXPERIMENTAL
Intervention: HoLEP
Number of subjects: 120

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 120
Study: 12742287

Group type: EXPERIMENTAL
Intervention: Stent implantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balloon percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 0
Study: 10507567

Group type: EXPERIMENTAL
Intervention: Topical brimonidine tartrate 0.2%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 60
Study: 8942375

Group type: EXPERIMENTAL
Intervention: Patching the fellow eye in infancy (intervention for unilateral congenital cataract)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sweep VEP method (used for estimating acuity)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Binocular controls (control group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Severe untreated uniocular visual impairment (comparison group)
Number of subjects: 12
Study: 1902417

Group type: EXPERIMENTAL
Intervention: Mitomycin or Adriamycin administered endovesically
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Cystoprostatourethrectomy
Number of subjects: 276
Study: 7078276

Group type: EXPERIMENTAL
Intervention: Computerized medical record summary system
Number of subjects: 479

Group type: COMPARATOR
Intervention: Manual record
Number of subjects: 479
Study: 29174738

Group type: EXPERIMENTAL
Intervention: Aripiprazole once-monthly 400mg (AOM 400)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26793971

Group type: EXPERIMENTAL
Intervention: Oral supplementation of essential amino acids (EAAs) for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24323795

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 17951

Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg
Number of subjects: 17951

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 17951

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg and 110 mg
Number of subjects: 17951
Study: 22509905

Group type: EXPERIMENTAL
Intervention: 500 μg nebulized ipratropium bromide
Number of subjects: 39

Group type: COMPARATOR
Intervention: saline placebo
Number of subjects: 39
Study: 20060665

Group type: EXPERIMENTAL
Intervention: Daily cholecalciferol 800 IU + calcium carbonate 1000 mg
Number of subjects: 3139

Group type: COMPARATOR
Intervention: Control group (no supplementation or placebo)
Number of subjects: 3139
Study: 18776199

Group type: EXPERIMENTAL
Intervention: BMSC transplantation
Number of subjects: 50
Study: 15668775

Group type: EXPERIMENTAL
Intervention: Real insoles
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo insoles
Number of subjects: 58
Study: 12208727

Group type: EXPERIMENTAL
Intervention: Conjunctival autograft transplantation (group A)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Limbal-conjunctival autograft transplantation (group B)
Number of subjects: 79
Study: 10086969

Group type: EXPERIMENTAL
Intervention: Etilefrine at a dosage of 75 mg/d
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 8650034

Group type: EXPERIMENTAL
Intervention: Patients with borderline essential hypertension
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High renin patients
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Normal renin patients
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (healthy men)
Number of subjects: 21
Study: 2402123

Group type: EXPERIMENTAL
Intervention: Cuprophane (Cu) dialysis membranes
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Polyacrylonitrile (PAN) dialysis membranes
Number of subjects: 8
Study: 6445050

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bupivacaine and Saline
Number of subjects: 20
Study: 6132936

Group type: EXPERIMENTAL
Intervention: Bromazepam (18 mg/day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Diazepam (15 mg/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 48
Study: 30897239

Group type: EXPERIMENTAL
Intervention: Silk garments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29973312

Group type: EXPERIMENTAL
Intervention: Text messages selected by participants (TM-PBS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Text messages selected by investigators (TM-PBS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Text messages selected at random (TM-PBS)
Number of subjects: 48
Study: 26658264

Group type: EXPERIMENTAL
Intervention: 200 mg modafinil
Number of subjects: 541

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 541
Study: 24780955

Group type: EXPERIMENTAL
Intervention: rTSMS (repetitive trans-spinal magnetic stimulation); a train of 40 stimuli
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 37
Study: 23110368

Group type: EXPERIMENTAL
Intervention: 150 mg NGX426
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 90 mg NGX426
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 20193083

Group type: EXPERIMENTAL
Intervention: Tai Chi program plus standard care
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 86
Study: 18829801

Group type: EXPERIMENTAL
Intervention: Cortisol levels in the upper quartile at baseline
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Cortisol values >90th percentile
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Cortisol values <10th percentile or >90th percentile
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Low cortisol values at baseline or day 5 to 7
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Low cortisol values
Number of subjects: 350

Group type: COMPARATOR
Intervention: Cortisol concentrations
Number of subjects: 350
Study: 15778883

Group type: EXPERIMENTAL
Intervention: 0.62 g/kg alcohol (A)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Reward for good performance during rising BACs (AR)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Reward for good performance during placebo (PR)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Declining BACs (73 mg/100 ml)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Declining BACs (64 mg/100 ml)
Number of subjects: 36
Study: 11815311

Group type: EXPERIMENTAL
Intervention: Margarine rich in ALA (15% ALA; n = 114)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Margarine rich in LA (0.3% ALA; n = 168)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Group nutritional education (n = 110; 50% ALA)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group (n = 172; 34% ALA)
Number of subjects: 282
Study: 10395399

Group type: COMPARATOR
Intervention: Group tube (direct injection into the upper end of the endotracheal tube)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Group EDGAR (endotracheal tube with an injection channel within the wall of the tube)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Group suction catheter (suction catheter placed into the bronchial system)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Group venous catheter (flexible venous catheter placed into the bronchial system)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Group suction tube (interruption of chest compressions and ventilation)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Group catheter (interruption of chest compressions and ventilation)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Group tube (interruption of chest compressions and ventilation)
Number of subjects: 35
Study: 7537116

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) 480 micrograms subcutaneously
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 21
Study: 2386449

Group type: EXPERIMENTAL
Intervention: +3 Gz
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Facing forward and facing backward conditions
Number of subjects: 5
Study: 7324741

Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia with 0.5% bupivacaine and epinephrine (5 micrograms/ml)
Number of subjects: 30

Group type: COMPARATOR
Intervention: General anaesthesia with nitrous oxide/oxygen, fentanyl, and pancuronium bromide
Number of subjects: 30
Study: 31199090

Group type: EXPERIMENTAL
Intervention: 1500 mg voxelotor
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: 900 mg voxelotor
Number of subjects: 274

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study: 28202260

Group type: COMPARATOR
Intervention: Allopurinol (Group A)
Number of subjects: 8047

Group type: COMPARATOR
Intervention: Benzbromarone (Group B)
Number of subjects: 8047

Group type: COMPARATOR
Intervention: Both drugs (Group A/B)
Number of subjects: 8047

Group type: EXPERIMENTAL
Intervention: Allopurinol (over 270 DDDs)
Number of subjects: 8047

Group type: EXPERIMENTAL
Intervention: Benzbromarone (over 360 DDDs)
Number of subjects: 8047
Study: 25616485

Group type: EXPERIMENTAL
Intervention: Responsive neurostimulation (RNS System)
Number of subjects: 230
Study: 23412403

Group type: EXPERIMENTAL
Intervention: Composite ceramic graft hydrated with bone marrow aspirate (group 1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Composite ceramic graft alone without bone marrow aspirate (group 2)
Number of subjects: 32
Study: 22018993

Group type: EXPERIMENTAL
Intervention: 7% hypertonic saline (HS)
Number of subjects: 32
Study: 18289333

Group type: EXPERIMENTAL
Intervention: 50% glycolic acid (GA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Occlusive dressing
Number of subjects: 20
Study: 16519969

Group type: EXPERIMENTAL
Intervention: On-line discussions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional group discussions
Number of subjects: 0
Study: 12946754

Group type: EXPERIMENTAL
Intervention: Intraoperative planning using a Mick applicator
Number of subjects: 300

Group type: COMPARATOR
Intervention: Preplanning using preloaded needles
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intraoperative method
Number of subjects: 300
Study: 11143776

Group type: EXPERIMENTAL
Intervention: ACE inhibitor, ramipril
Number of subjects: 0
Study: 9292644

Group type: EXPERIMENTAL
Intervention: PGE2
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Ethacridine lactate
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: PGE2+oxytocin infusion
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Ethacridine lactate+oxytocin infusion
Number of subjects: 151
Study: 8387988

Group type: EXPERIMENTAL
Intervention: Total resection
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Partial resection
Number of subjects: 645

Group type: COMPARATOR
Intervention: Biopsy only
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Frontal lobe tumors
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Temporal lobe tumors
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Parietal lobe tumors
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: At least three favorable features (<40 years, high Karnofsky Performance Status, frontal tumors, total resection)
Number of subjects: 645
Study: 3800032

Group type: EXPERIMENTAL
Intervention: Propranolol, 40 mg orally every 6 h, beginning 24 h prior to bupivacaine administration
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control session (no propranolol)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 6
Study: 29265831

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy (MBCT)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 166
Study: 28714772

Group type: EXPERIMENTAL
Intervention: Healthy Families Durham (HFD) home visiting program
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Infant attachment disorganization
Number of subjects: 94
Study: 23834197

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blockers
Number of subjects: 0
Study: 24195781

Group type: EXPERIMENTAL
Intervention: Training in the application of the Dutch guideline on assessment and treatment of suicidal behavior via a 1-day small interactive group training program supported by e-learning modules.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual dissemination of the guideline (internet, newsletter, books, publications, and congresses) without additional training.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training in the application of the guideline.
Number of subjects: 0
Study: 21377738

Group type: EXPERIMENTAL
Intervention: Self-stigma reduction program (N=34)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Newspaper reading group (N=32)
Number of subjects: 66
Study: 18258368

Group type: EXPERIMENTAL
Intervention: Gabapentin (up to 2400 mg/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 16406190

Group type: EXPERIMENTAL
Intervention: Metformin (2500 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Glimepiride (8 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both drugs (metformin and glimepiride)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 14649343

Group type: EXPERIMENTAL
Intervention: Intrathecal midazolam (2 mg) added to hyperbaric bupivacaine (15 mg) and buprenorphine (0.15 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine (15 mg) plus buprenorphine (0.15 mg)
Number of subjects: 60
Study: 10992829

Group type: EXPERIMENTAL
Intervention: Local morphine (2 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Systemic morphine (2 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8616287

Group type: EXPERIMENTAL
Intervention: Use of Ottawa ankle rules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard radiographic examinations
Number of subjects: 0
Study: 1399498

Group type: EXPERIMENTAL
Intervention: Nisoldipine 5 mg twice a day for 2 weeks
Number of subjects: 12
Study: 3908737

Group type: EXPERIMENTAL
Intervention: Lenampicillin (LAPC)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Talampicillin (TAPC)
Number of subjects: 238
Study: 31235821

Group type: EXPERIMENTAL
Intervention: Diquafosol
Number of subjects: 47

Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 47